Dominique Limet, the CEO of ViiV Healthcare, a global pharma company devoted to the treatment and care of people living with HIV, is stepping down in March 2017, according to a ViiV press release. Deborah Waterhouse has been named CEO designate, beginning January 1, 2017.

Limet has led ViiV Healthcare since its establishment in 2009 by GlaxoSmithKline (GSK) and Pfizer (Japanese pharmaceutical company Shionogi joined in 2012). Earlier in his career, he was a general practitioner in France before working for GSK in France and Eastern Europe.

Waterhouse joined GSK in 1996; she led the vaccines business in the United States as well as the HIV business in the United Kingdom, and she headed the HIV Centre of Excellence for Pharma Europe.

“Establishing and then leading ViiV Healthcare for the past seven years has been an incredible honor and extremely fulfilling personally,” Limet said in the press release. “I have had the pleasure to work with an exceptional team and am proud of how the business has grown to its current position as a leader in HIV therapy. We have delivered scientific innovation, while listening and better understanding the needs of people living with HIV, allowing us to both do good and do well as a business. The future looks extremely promising for ViiV Healthcare.”

“ViiV Healthcare has an impeccable reputation for strong performance and a culture that thrives on challenge,” Waterhouse added. “I’m honored to have the opportunity to lead such an exciting endeavor, and to build on the advances that Dominique and the ViiV Healthcare organization have made to HIV treatment and care.”